A gut-lung connection influences susceptibility to infection by Acinetobacter baumannii, a leading cause of hospital-acquired ...

A gut-lung connection influences susceptibility to infection by Acinetobacter baumannii, a leading cause of hospital-acquired ...

BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP) caused by carbapenem-resistant ...

Taiwanese researchers have unlocked a key mechanism of a so-called “superbug” in a breakthrough that could lead to improved vaccines and treatment strategies to counter the pathogen.

Asymptomatic bacteriuria (ASB) is defined as the presence of ≥100,000 colony-forming units (CFU)/mL of bacteria in a ...

BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections ...

Dar es Salaam. A comprehensive new study has raised concern over a “critical and troubling” rise in antimicrobial resistance (AMR) across Tanzania, showing that many commonly used antibiotics are ...

A biohybrid nanorobot pairs a bacterial virus with catalytic nanoparticles to destroy drug-resistant biofilms and shred the ...

Muneer Yaqub, a Nigerian researcher and PhD graduate of the University of Texas at Dallas, United States, recently earned ...

A Hospital-based Cross-sectional Study,” the research was published in March 2026 in the National Journal of Laboratory ...

Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, is presenting a full suite of preclinical findings from the company’s lead candidate, ...